Ind-Swift Laboratories Ltd - Shs Dematerialised

NSE:INDSWFTLAB (India)   Shs Dematerialised
₹ 112.90 (+2.87%) May 15
14.69
P/B:
0.87
Market Cap:
₹ 6.67B ($ 79.93M)
Enterprise V:
₹ 14.34B ($ 171.84M)
Volume:
1.22M
Avg Vol (2M):
1.34M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Ind-Swift Laboratories Ltd ( ) from 1997 to May 16 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Ind-Swift Laboratories stock (NSE:INDSWFTLAB) PE ratio as of May 16 2024 is 14.69. More Details

Ind-Swift Laboratories Ltd (NSE:INDSWFTLAB) PE Ratio (TTM) Chart

To

Ind-Swift Laboratories Ltd (NSE:INDSWFTLAB) PE Ratio (TTM) Historical Data

Total 1277
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Ind-Swift Laboratories PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-16 15.3 2024-03-14 14.0
2024-05-15 15.3 2024-03-13 14.0
2024-05-14 14.9 2024-03-12 14.5
2024-05-13 14.3 2024-03-11 14.1
2024-05-10 14.7 2024-03-08 14.4
2024-05-09 14.3 2024-03-07 14.4
2024-05-08 14.9 2024-03-06 14.9
2024-05-07 15.0 2024-03-05 14.8
2024-05-06 15.3 2024-03-04 14.7
2024-05-03 15.8 2024-03-01 15.1
2024-05-02 16.8 2024-02-29 14.7
2024-05-01 16.3 2024-02-28 14.5
2024-04-30 16.3 2024-02-27 15.1
2024-04-29 16.6 2024-02-26 15.2
2024-04-26 17.0 2024-02-23 15.3
2024-04-25 16.9 2024-02-22 15.4
2024-04-24 16.7 2024-02-21 14.8
2024-04-23 16.8 2024-02-20 15.1
2024-04-22 16.1 2024-02-19 14.5
2024-04-19 16.1 2024-02-16 14.4
2024-04-18 15.8 2024-02-15 14.0
2024-04-17 16.4 2024-02-14 13.8
2024-04-16 16.4 2024-02-13 13.4
2024-04-15 16.5 2024-02-12 14.0
2024-04-12 17.7 2024-02-09 15.1
2024-04-11 17.1 2024-02-08 15.8
2024-04-10 17.1 2024-02-07 15.7
2024-04-09 17.9 2024-02-06 14.8
2024-04-08 18.0 2024-02-05 14.6
2024-04-05 17.4 2024-02-02 14.7
2024-04-04 15.2 2024-02-01 14.5
2024-04-03 15.1 2024-01-31 14.9
2024-04-02 13.8 2024-01-30 14.7
2024-04-01 13.7 2024-01-29 14.2
2024-03-29 13.6 2024-01-26 14.2
2024-03-28 13.6 2024-01-25 14.2
2024-03-27 13.1 2024-01-24 14.3
2024-03-26 12.9 2024-01-23 13.9
2024-03-25 13.7 2024-01-22 14.5
2024-03-22 13.7 2024-01-19 14.5
2024-03-21 14.1 2024-01-18 14.5
2024-03-20 14.2 2024-01-17 14.2
2024-03-19 14.3 2024-01-16 14.3
2024-03-18 14.5 2024-01-15 14.2
2024-03-15 14.1 2024-01-12 14.5

Ind-Swift Laboratories Ltd (NSE:INDSWFTLAB) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Ind-Swift Laboratories Ltd is engaged in the business of active pharmaceutical ingredients (API). The company caters to diverse therapeutic segments namely Cardiovascular health, Antihistamine, Antidiabetic, Antipsychotic, Parkinson's Disease, Antineoplastic, ADHD Symptoms, Analgesics, Alcohol Abstinence, and Bone Resorption Inhibitor. Geographically, it derives a majority of revenue from Outside India.